These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8096121)

  • 1. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.
    Persons DL; Hartmann LC; Herath JF; Borell TJ; Cliby WA; Keeney GL; Jenkins RB
    Am J Pathol; 1993 Mar; 142(3):733-41. PubMed ID: 8096121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase cytogenetic analysis of mucinous ovarian neoplasms.
    Diebold J; Siegert S; Baretton GB; Suchy B; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1997 May; 76(5):661-70. PubMed ID: 9166285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of numerical chromosome anomalies in interphase cells of ovarian carcinomas using fluorescence in situ hybridization.
    Brock JA; Liu WH; Smith ST; Young SR
    Genes Chromosomes Cancer; 1996 Jun; 16(2):120-9. PubMed ID: 8818659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
    Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
    Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2/neu oncogene amplification in stage I and stage III ovarian papillary serous carcinoma.
    Afify AM; Werness BA; Mark HF
    Exp Mol Pathol; 1999 Jun; 66(2):163-9. PubMed ID: 10409445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization.
    Hamon-Benais C; Ingster O; Terris B; Couturier-Turpin MH; Bernheim A; Feldmann G
    Hepatology; 1996 Mar; 23(3):429-35. PubMed ID: 8617421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric quantification of human chromosome specific repetitive DNA sequences by single and bicolor fluorescent in situ hybridization to lymphocyte interphase nuclei.
    van Dekken H; Arkesteijn GJ; Visser JW; Bauman JG
    Cytometry; 1990; 11(1):153-64. PubMed ID: 2307056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Her-2/neu expression and amplification in early stage ovarian surface epithelial neoplasms.
    Wu Y; Soslow RA; Marshall DS; Leitao M; Chen B
    Gynecol Oncol; 2004 Dec; 95(3):570-5. PubMed ID: 15581965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic study of 121 patients suffering from various hematologic neoplasms using the in situ hybridization technique].
    Pérez Losada A; Solé F; Woessner S; Florensa L; Besses C; Espinet B; Caballín MR; García Eroles L; Sans-Sabrafén J
    Sangre (Barc); 1996 Jun; 41(3):201-9. PubMed ID: 8755208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative interphase cytogenetics using FISH on human ovarian carcinomas.
    Liehr T; Stübinger A; Thoma K; Tulusan HA; Gebhart E
    Anticancer Res; 1994; 14(1A):183-8. PubMed ID: 8166447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe.
    Kalir T; Eisberg A; Dottino P; Cohen C
    Gynecol Oncol; 1999 Feb; 72(2):208-14. PubMed ID: 10021303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical sex chromosomal abnormalities in pineal teratomas by cytogenetic analysis and fluorescence in situ hybridization.
    Yu IT; Griffin CA; Phillips PC; Strauss LC; Perlman EJ
    Lab Invest; 1995 Apr; 72(4):419-23. PubMed ID: 7723280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization.
    Baretton GB; Valina C; Vogt T; Schneiderbanger K; Diebold J; Löhrs U
    Cancer Res; 1994 Aug; 54(16):4472-80. PubMed ID: 8044798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERBB2 and chromosome 17 centromere studies of ovarian cancer by fluorescence in situ hybridization.
    Young SR; Liu WH; Brock JA; Smith ST
    Genes Chromosomes Cancer; 1996 Jun; 16(2):130-7. PubMed ID: 8818660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A degenerate alpha satellite probe, detecting a centromeric deletion on chromosome 21 in an apparently normal human male, shows limitations of the use of satellite DNA probes for interphase ploidy analysis.
    Weier HU; Gray JW
    Anal Cell Pathol; 1992 Mar; 4(2):81-6. PubMed ID: 1550797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization.
    Jimenez RE; Wallis T; Tabasczka P; Visscher DW
    Mod Pathol; 2000 Jan; 13(1):37-45. PubMed ID: 10658908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How is Her-2/neu status established when Her-2/neu and chromosome 17 centromere are both amplified?
    Press MF
    Am J Clin Pathol; 2006 Nov; 126(5):673-4. PubMed ID: 17050063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.